Research programme: connective tissue regeneration therapies - Bio3 Research

Drug Profile

Research programme: connective tissue regeneration therapies - Bio3 Research

Alternative Names: CTR-1; CTR-2; CTR-3; CTR-4

Latest Information Update: 04 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bio3 Research
  • Class
  • Mechanism of Action Protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Bone disorders; Cartilage disorders; Musculoskeletal disorders; Wounds

Most Recent Events

  • 04 Feb 2011 Preclinical development is ongoing in Italy
  • 12 Feb 2007 Preclinical development is ongoing
  • 16 Aug 2005 Preclinical trials in Wounds in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top